The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.
Saved in:
| Title: | The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors. |
|---|---|
| Authors: | Bissonnette RP; HUYABIO International, LLC, San Diego, CA, USA., Cesario RM; HUYABIO International, LLC, San Diego, CA, USA., Goodenow B; HUYABIO International, LLC, San Diego, CA, USA., Shojaei F; HUYABIO International, LLC, San Diego, CA, USA. fshojaei@huyabio.com., Gillings M; HUYABIO International, LLC, San Diego, CA, USA. |
| Source: | BMC cancer [BMC Cancer] 2021 Aug 30; Vol. 21 (1), pp. 969. Date of Electronic Publication: 2021 Aug 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34461854 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bissonnette+RP%22">Bissonnette RP</searchLink>; HUYABIO International, LLC, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cesario+RM%22">Cesario RM</searchLink>; HUYABIO International, LLC, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Goodenow+B%22">Goodenow B</searchLink>; HUYABIO International, LLC, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shojaei+F%22">Shojaei F</searchLink>; HUYABIO International, LLC, San Diego, CA, USA. fshojaei@huyabio.com.<br /><searchLink fieldCode="AU" term="%22Gillings+M%22">Gillings M</searchLink>; HUYABIO International, LLC, San Diego, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2021 Aug 30; Vol. 21 (1), pp. 969. <i>Date of Electronic Publication: </i>2021 Aug 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34461854 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-021-08702-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 969 Titles: – TitleFull: The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bissonnette RP – PersonEntity: Name: NameFull: Cesario RM – PersonEntity: Name: NameFull: Goodenow B – PersonEntity: Name: NameFull: Shojaei F – PersonEntity: Name: NameFull: Gillings M IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 08 Text: 2021 Aug 30 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |
